China in Talks With Pfizer for Generic COVID Drug: Sources
China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's COVID-19 antiviral drug Paxlovid in China.
Reuters Health Information
source https://www.medscape.com/viewarticle/986604?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/986604?src=rss
Comments
Post a Comment